CTIC logo

CTI BioPharma (CTIC) CAPEX

Annual CAPEX

$25.00 M
NaN%

December 31, 2022

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

+50920.41%

15-Year Change

+50920.41%

CTIC CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$25.00 M
CTIC annual capital expenditures is currently at an all-time high

3-Year Low

$25.00 M
CTIC annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CTIC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CTIC next annual earnings announcement has not yet been scheduled

OtherCTICcash flowmetrics:

Annual FCF

-$106.19 M
CTIC annual free cash flow is -$106.19 million

Annual CFO

-$81.19 M
CTIC annual cash flow from operations is -$81.19 million

Annual CFI

-$73.85 M
CTIC annual cash flow from investing activities is -$73.85 million

Annual CFF

$120.02 M
CTIC annual cash flow from financing activities is $120.02 million

Quarterly CAPEX

N/A

March 31, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CTIC Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$25.00 M
CTIC quarterly capital expenditures is currently at an all-time high

3-Year Low

$0.00
CTIC quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICcash flowmetrics:

Quarterly FCF

-$31.10 M
CTIC quarterly free cash flow is -$31.10 million

Quarterly CFO

-$31.10 M
CTIC quarterly cash flow from operations is -$31.10 million

Quarterly CFI

$15.26 M
CTIC quarterly cash flow from investing activities is $15.26 million

Quarterly CFF

$9.63 M
CTIC quarterly cash flow from financing activities is $9.63 million

TTM CAPEX

N/A

March 31, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CTIC TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$25.00 M
CTIC TTM capital expenditures is currently at an all-time high

3-Year Low

$25.00 M
CTIC TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
CTIC previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
CTIC next earnings announcement has not yet been scheduled

OtherCTICcash flowmetrics:

TTM FCF

-$107.31 M
CTIC TTM free cash flow is -$107.31 million

TTM CFO

-$82.31 M
CTIC TTM cash flow from operations is -$82.31 million

TTM CFI

-$58.60 M
CTIC TTM cash flow from investing activities is -$58.60 million

TTM CFF

$68.22 M
CTIC TTM cash flow from financing activities is $68.22 million

CTIC CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years+10000.0%--

CTIC CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-yearat high-99.9%
alltimeall timeat high-99.9%

CTI BioPharma CAPEX History

DateAnnualQuarterlyTTM
Dec 2022
$25.00 M(>+9900.0%)
$0.00(-100.0%)
$25.00 M(0.0%)
Sep 2022
-
$25.00 M(>+9900.0%)
$25.00 M(>+9900.0%)
Dec 2020
$17.00 K(-48.5%)
-
-
Dec 2018
$33.00 K(-32.7%)
$0.00(0.0%)
$33.00 K(0.0%)
Sep 2018
-
$0.00(0.0%)
$33.00 K(0.0%)
Jun 2018
-
$0.00(-100.0%)
$33.00 K(0.0%)
Mar 2018
-
$33.00 K(>+9900.0%)
$33.00 K(-75.9%)
Dec 2017
$49.00 K(-64.2%)
-
-
Dec 2016
$137.00 K(+75.6%)
$0.00(-100.0%)
$137.00 K(-25.5%)
Sep 2016
-
$29.00 K(-63.3%)
$184.00 K(+13.6%)
Jun 2016
-
$79.00 K(+172.4%)
$162.00 K(+95.2%)
Mar 2016
-
$29.00 K(-38.3%)
$83.00 K(+6.4%)
Dec 2015
$78.00 K(-76.6%)
$47.00 K(+571.4%)
$78.00 K(-26.4%)
Sep 2015
-
$7000.00(>+9900.0%)
$106.00 K(-64.5%)
Jun 2015
-
$0.00(-100.0%)
$299.00 K(-7.1%)
Mar 2015
-
$24.00 K(-68.0%)
$322.00 K(-3.3%)
Dec 2014
$333.00 K(-79.9%)
$75.00 K(-62.5%)
$333.00 K(-38.6%)
Sep 2014
-
$200.00 K(+769.6%)
$542.00 K(+50.6%)
Jun 2014
-
$23.00 K(-34.3%)
$360.00 K(-46.6%)
Mar 2014
-
$35.00 K(-87.7%)
$674.00 K(-59.3%)
Dec 2013
$1.66 M(-43.6%)
$284.00 K(+1477.8%)
$1.66 M(-29.3%)
Sep 2013
-
$18.00 K(-94.7%)
$2.34 M(-28.2%)
Jun 2013
-
$337.00 K(-66.9%)
$3.26 M(-12.8%)
Mar 2013
-
$1.02 M(+4.8%)
$3.74 M(+27.4%)
Dec 2012
$2.94 M(+8.7%)
$971.00 K(+3.6%)
$2.94 M(+9.0%)
Sep 2012
-
$937.00 K(+15.0%)
$2.69 M(+5.1%)
Jun 2012
-
$815.00 K(+280.8%)
$2.56 M(-1.0%)
Mar 2012
-
$214.00 K(-70.6%)
$2.59 M(-4.2%)
Dec 2011
$2.70 M(+34.4%)
$729.00 K(-9.7%)
$2.70 M(-1.8%)
Sep 2011
-
$807.00 K(-3.9%)
$2.75 M(+34.0%)
Jun 2011
-
$840.00 K(+156.9%)
$2.05 M(+68.4%)
Mar 2011
-
$327.00 K(-58.0%)
$1.22 M(-39.3%)
Dec 2010
$2.01 M(+36.1%)
$779.00 K(+621.3%)
$2.01 M(-15.0%)
Sep 2010
-
$108.00 K(+1700.0%)
$2.37 M(+1.7%)
Jun 2010
-
$6000.00(-99.5%)
$2.33 M(-10.4%)
Mar 2010
-
$1.12 M(-1.5%)
$2.60 M(+75.6%)
Dec 2009
$1.48 M(-22.5%)
$1.14 M(+1569.1%)
$1.48 M(+48.1%)
Sep 2009
-
$68.00 K(-75.3%)
$998.00 K(-31.3%)
Jun 2009
-
$275.00 K(-58.0%)
$1.45 M(-23.8%)
Dec 2008
$1.91 M(+8.8%)
$655.00 K(+25.2%)
$1.91 M(-1.7%)
Sep 2008
-
$523.00 K(+7.4%)
$1.94 M(+10.9%)
Jun 2008
-
$487.00 K(+101.2%)
$1.75 M(-3.0%)
Mar 2008
-
$242.00 K(-64.8%)
$1.80 M(+2.9%)
Dec 2007
$1.75 M
$687.00 K(+106.3%)
$1.75 M(+55.4%)
DateAnnualQuarterlyTTM
Sep 2007
-
$333.00 K(-38.6%)
$1.13 M(+22.7%)
Jun 2007
-
$542.00 K(+183.8%)
$919.00 K(+52.4%)
Mar 2007
-
$191.00 K(+208.1%)
$603.00 K(+12.9%)
Dec 2006
$534.00 K(-73.5%)
$62.00 K(-50.0%)
$534.00 K(-1.5%)
Sep 2006
-
$124.00 K(-45.1%)
$542.00 K(+29.0%)
Jun 2006
-
$226.00 K(+85.2%)
$420.00 K(-32.8%)
Mar 2006
-
$122.00 K(+74.3%)
$625.00 K(-69.0%)
Dec 2005
$2.02 M(-56.5%)
$70.00 K(+3400.0%)
$2.02 M(-40.9%)
Sep 2005
-
$2000.00(-99.5%)
$3.41 M(-25.5%)
Jun 2005
-
$431.00 K(-71.5%)
$4.58 M(-15.1%)
Mar 2005
-
$1.51 M(+3.3%)
$5.39 M(+16.5%)
Dec 2004
$4.63 M(+38.9%)
$1.46 M(+25.0%)
$4.63 M(+16.5%)
Sep 2004
-
$1.17 M(-6.1%)
$3.98 M(+11.6%)
Jun 2004
-
$1.25 M(+66.3%)
$3.56 M(-5.5%)
Mar 2004
-
$750.00 K(-7.2%)
$3.77 M(+13.0%)
Dec 2003
$3.33 M(-46.7%)
$808.00 K(+6.5%)
$3.33 M(-16.8%)
Sep 2003
-
$759.00 K(-47.8%)
$4.01 M(-4.3%)
Jun 2003
-
$1.45 M(+361.3%)
$4.19 M(+14.5%)
Mar 2003
-
$315.00 K(-78.7%)
$3.66 M(-41.5%)
Dec 2002
$6.26 M(+5.4%)
$1.48 M(+57.8%)
$6.26 M(-12.3%)
Sep 2002
-
$939.00 K(+1.6%)
$7.13 M(-12.7%)
Jun 2002
-
$924.00 K(-68.3%)
$8.17 M(+5.4%)
Mar 2002
-
$2.91 M(+23.6%)
$7.75 M(+30.6%)
Dec 2001
$5.94 M(+523.1%)
$2.36 M(+19.4%)
$5.94 M(+38.6%)
Sep 2001
-
$1.97 M(+289.1%)
$4.29 M(+73.4%)
Jun 2001
-
$507.40 K(-53.8%)
$2.47 M(+22.3%)
Mar 2001
-
$1.10 M(+55.7%)
$2.02 M(+112.1%)
Dec 2000
$953.00 K(+58.8%)
$705.50 K(+339.0%)
$953.00 K(+74.1%)
Sep 2000
-
$160.70 K(+183.9%)
$547.50 K(+12.5%)
Jun 2000
-
$56.60 K(+87.4%)
$486.80 K(-8.2%)
Mar 2000
-
$30.20 K(-89.9%)
$530.20 K(-11.6%)
Dec 1999
$600.00 K(-78.6%)
$300.00 K(+200.0%)
$600.00 K(0.0%)
Sep 1999
-
$100.00 K(0.0%)
$600.00 K(-40.0%)
Jun 1999
-
$100.00 K(0.0%)
$1.00 M(-44.4%)
Mar 1999
-
$100.00 K(-66.7%)
$1.80 M(-35.7%)
Dec 1998
$2.80 M(+12.0%)
$300.00 K(-40.0%)
$2.80 M(-15.2%)
Sep 1998
-
$500.00 K(-44.4%)
$3.30 M(0.0%)
Jun 1998
-
$900.00 K(-18.2%)
$3.30 M(+13.8%)
Mar 1998
-
$1.10 M(+37.5%)
$2.90 M(+16.0%)
Dec 1997
$2.50 M(+150.0%)
$800.00 K(+60.0%)
$2.50 M(+47.1%)
Sep 1997
-
$500.00 K(0.0%)
$1.70 M(+41.7%)
Jun 1997
-
$500.00 K(-28.6%)
$1.20 M(+71.4%)
Mar 1997
-
$700.00 K
$700.00 K
Dec 1996
$1.00 M
-
-

FAQ

  • What is CTI BioPharma annual capital expenditures?
  • What is the all time high annual CAPEX for CTI BioPharma?
  • What is the all time high quarterly CAPEX for CTI BioPharma?
  • What is the all time high TTM CAPEX for CTI BioPharma?

What is CTI BioPharma annual capital expenditures?

The current annual CAPEX of CTIC is $25.00 M

What is the all time high annual CAPEX for CTI BioPharma?

CTI BioPharma all-time high annual capital expenditures is $25.00 M

What is the all time high quarterly CAPEX for CTI BioPharma?

CTI BioPharma all-time high quarterly capital expenditures is $25.00 M

What is the all time high TTM CAPEX for CTI BioPharma?

CTI BioPharma all-time high TTM capital expenditures is $25.00 M